The Maine Principal's Association released a statement addressing scrutiny toward its president and its refusal to ban trans ...

The federal appellate court rejected an out-of-state employee's Minnesota Human Rights Act claims against her former ...

The UK regulator has been redesignated as one of the WHO’s collaborating centres for the standardisation and evaluation of ...

In 2023, a report by Lord James O’Shaughnessy found the UK had dropped from fourth to tenth as global contributors to ...

First-ever MHRA analysis of UK clinical trial applications finds new opportunities to drive medical breakthroughs for patients: United Kingdom Friday, April 11, 2025, 18:00 Hrs [I ...

12-month roll-out begins today for the biggest regulatory shake up of clinical trials in 20 years ...

New analysis of the current clinical trial landscape in the UK shows clear opportunities to shape the future of medical research and patient care. The ...

The MHRA has approved eplontersen (Wainzua) for treating adults with polyneuropathy associated with hereditary transthyretin ...

The MHRA has approved trofolastat to identify how far high-risk prostate cancer has spread before treatment, to detect ...

On March 17, 2025, the government published a policy paper with an Action Plan for regulation and regulators, outlining how it intends to reform ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...